Literature DB >> 19752160

Array comparative genomic hybridisation of 52 subjects with a Smith-Magenis-like phenotype: identification of dosage sensitive loci also associated with schizophrenia, autism, and developmental delay.

Stephen R Williams1, Santhosh Girirajan, David Tegay, Norma Nowak, Eli Hatchwell, Sarah H Elsea.   

Abstract

BACKGROUND: Smith-Magenis syndrome (SMS) is caused by del(17)(p11.2), including the retinoic acid induced 1 gene (RAI1), or mutation of RAI1. Haploinsufficiency of RAI1 results in developmental delay, mental retardation, sleep disturbance, self-abusive behaviors, and most features commonly seen in SMS. In this study, 52 subjects were referred for molecular analysis of RAI1 due to the presence of an SMS-like phenotype in each case. For this cohort, deletion and mutation analyses of RAI1 were negative; thus, the clinical diagnosis of SMS could not be confirmed and suggested that at least one other locus was responsible for the phenotype(s) observed.
METHODS: Here, we present whole-genome array comparative genomic hybridization and detailed phenotypic data of these 52 subjects.
RESULTS: This SMS-like cohort exhibited developmental delays, sleep disturbance, self-abusive behaviors, motor dysfunction, and hyperactivity of the same type and prevalence as that of SMS. In this analysis, we identified at least 5 new loci that likely contribute to the SMS-like phenotype, including CNVs that were found in more than one subject. Genes in these regions function in development, neurological integrity, and morphology, all of which are affected in SMS.
CONCLUSIONS: Given the phenotypic overlap between SMS and the SMS-like cases, these data may provide some insight into the function of RAI1, including the pathways in which it may be involved and the genes it may regulate. These data will improve diagnosis, understanding, and potentially treatment of these complex behavior and mental retardation syndromes.

Entities:  

Mesh:

Year:  2009        PMID: 19752160     DOI: 10.1136/jmg.2009.068072

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  10 in total

1.  Reorganization of inter-chromosomal interactions in the 2q37-deletion syndrome.

Authors:  Philipp G Maass; Anja Weise; Katharina Rittscher; Julia Lichtenwald; A Rasim Barutcu; Thomas Liehr; Atakan Aydin; Yvette Wefeld-Neuenfeld; Laura Pölsler; Sigrid Tinschert; John L Rinn; Friedrich C Luft; Sylvia Bähring
Journal:  EMBO J       Date:  2018-06-19       Impact factor: 11.598

2.  Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems.

Authors:  Stephen R Williams; Micheala A Aldred; Vazken M Der Kaloustian; Fahed Halal; Gordon Gowans; D Ross McLeod; Sara Zondag; Helga V Toriello; R Ellen Magenis; Sarah H Elsea
Journal:  Am J Hum Genet       Date:  2010-08-13       Impact factor: 11.025

3.  Detection of classical 17p11.2 deletions, an atypical deletion and RAI1 alterations in patients with features suggestive of Smith-Magenis syndrome.

Authors:  Gustavo H Vieira; Jayson D Rodriguez; Paulina Carmona-Mora; Lei Cao; Bruno F Gamba; Daniel R Carvalho; Andréa de Rezende Duarte; Suely R Santos; Deise H de Souza; Barbara R DuPont; Katherina Walz; Danilo Moretti-Ferreira; Anand K Srivastava
Journal:  Eur J Hum Genet       Date:  2011-09-07       Impact factor: 4.246

4.  Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures.

Authors:  Stephen R Williams; Sureni V Mullegama; Jill A Rosenfeld; Aditi I Dagli; Eli Hatchwell; William P Allen; Charles A Williams; Sarah H Elsea
Journal:  Eur J Hum Genet       Date:  2009-11-11       Impact factor: 4.246

5.  Phenotypic variant of Brachydactyly-mental retardation syndrome in a family with an inherited interstitial 2q37.3 microdeletion including HDAC4.

Authors:  Pablo Villavicencio-Lorini; Eva Klopocki; Marc Trimborn; Randi Koll; Stefan Mundlos; Denise Horn
Journal:  Eur J Hum Genet       Date:  2012-11-28       Impact factor: 4.246

6.  Molecular analysis of the Retinoic Acid Induced 1 gene (RAI1) in patients with suspected Smith-Magenis syndrome without the 17p11.2 deletion.

Authors:  Thierry Vilboux; Carla Ciccone; Jan K Blancato; Gerald F Cox; Charu Deshpande; Wendy J Introne; William A Gahl; Ann C M Smith; Marjan Huizing
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

Review 7.  Congenital scoliosis in Smith-Magenis syndrome: a case report and review of the literature.

Authors:  Zheng Li; Jianxiong Shen; Jinqian Liang; Lin Sheng
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

8.  Investigation of selected genomic deletions and duplications in a cohort of 338 patients presenting with syndromic obesity by multiplex ligation-dependent probe amplification using synthetic probes.

Authors:  Carla S D'Angelo; Monica C Varela; Cláudia Ie de Castro; Chong A Kim; Débora R Bertola; Charles M Lourenço; Ana Beatriz A Perez; Celia P Koiffmann
Journal:  Mol Cytogenet       Date:  2014-10-31       Impact factor: 2.009

9.  Identification of a RAI1-associated disease network through integration of exome sequencing, transcriptomics, and 3D genomics.

Authors:  Maria Nicla Loviglio; Christine R Beck; Janson J White; Marion Leleu; Tamar Harel; Nicolas Guex; Anne Niknejad; Weimin Bi; Edward S Chen; Isaac Crespo; Jiong Yan; Wu-Lin Charng; Shen Gu; Ping Fang; Zeynep Coban-Akdemir; Chad A Shaw; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Jacques Rougemont; Ioannis Xenarios; James R Lupski; Alexandre Reymond
Journal:  Genome Med       Date:  2016-11-01       Impact factor: 11.117

Review 10.  A Link between Genetic Disorders and Cellular Impairment, Using Human Induced Pluripotent Stem Cells to Reveal the Functional Consequences of Copy Number Variations in the Central Nervous System-A Close Look at Chromosome 15.

Authors:  Alessia Casamassa; Daniela Ferrari; Maurizio Gelati; Massimo Carella; Angelo Luigi Vescovi; Jessica Rosati
Journal:  Int J Mol Sci       Date:  2020-03-09       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.